
- Cancer
- Trials in setup
PEMoLA
A Phase II study combining pembrolizumab and olaparib in metastatic pancreatic adenocarcinoma patient with high tumour mutation burden
Research summary
Information coming soon
A Phase II study combining pembrolizumab and olaparib in metastatic pancreatic adenocarcinoma patient with high tumour mutation burden
Information coming soon